Eton Pharmaceuticals ROA 2018-2020 | ETON

Current and historical return on assets (ROA) values for Eton Pharmaceuticals (ETON) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Eton Pharmaceuticals ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2020-09-30 $-0.02B $0.01B -160.00%
2020-06-30 $-0.02B $0.02B -139.68%
2020-03-31 $-0.02B $0.02B -121.21%
2019-12-31 $-0.02B $0.02B -100.00%
2019-09-30 $-0.04B $0.01B -197.59%
2019-06-30 $-0.04B $0.02B -207.79%
2019-03-31 $-0.04B $0.02B -277.97%
2018-12-31 $-0.04B $0.03B -422.22%
2018-06-30 $-0.01B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.209B $0.000B
Eton Pharmaceuticals Inc. operates as a development stage biotechnology company. Its product pipeline consists of DS-300, EM-100, DS-100, DS-200, ET-103, ET-101, ET-102 and CT-100 which are in clinical stage. Eton Pharmaceuticals Inc. is based in Deer Park, Illinois.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $146.464B 10.44
Amgen (AMGN) United States $138.405B 14.47
CSL (CSLLY) Australia $96.318B 0.00
Gilead Sciences (GILD) United States $77.142B 10.26
Vertex Pharmaceuticals (VRTX) United States $59.055B 27.46
Regeneron Pharmaceuticals (REGN) United States $54.623B 19.38
Illumina (ILMN) United States $52.852B 72.69
Moderna (MRNA) United States $49.092B 0.00
Biogen (BIIB) United States $41.036B 7.29
Alexion Pharmaceuticals (ALXN) United States $34.236B 13.64
Seagen (SGEN) United States $31.962B 84.14
BeiGene (BGNE) Cayman Islands $28.201B 0.00
Genmab (GMAB) Denmark $28.073B 33.20
Genmab (GNMSF) Denmark $26.488B 6.10
BioNTech SE (BNTX) Germany $23.217B 0.00
Exact Sciences (EXAS) United States $21.867B 0.00
Incyte (INCY) United States $20.310B 0.00
Alnylam Pharmaceuticals (ALNY) United States $19.859B 0.00
Bio-Rad Laboratories (BIO.B) United States $18.067B 68.51
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.372B 0.00
Horizon Therapeutics Public (HZNP) Ireland $17.017B 24.32
Guardant Health (GH) United States $15.932B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.875B 98.72
CRISPR Therapeutics AG (CRSP) Switzerland $13.803B 0.00
ARGENX SE-ADR (ARGX) Netherlands $12.974B 0.00
Bio-Techne Corp (TECH) United States $12.763B 81.63
QIAGEN (QGEN) Netherlands $12.146B 27.35
Repligen (RGEN) United States $10.943B 155.20
Mirati Therapeutics (MRTX) United States $10.155B 0.00
Fate Therapeutics (FATE) United States $9.884B 0.00
Denali Therapeutics (DNLI) United States $9.138B 0.00
Ascendis Pharma (ASND) Denmark $8.840B 0.00
Adaptive Biotechnologies (ADPT) United States $8.684B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.475B 0.00
Ultragenyx Pharmaceutical (RARE) United States $8.223B 0.00
Twist Bioscience (TWST) United States $8.187B 0.00
Novavax (NVAX) United States $8.035B 0.00
Exelixis (EXEL) United States $7.561B 50.77
Acceleron Pharma (XLRN) United States $7.431B 0.00
Sarepta Therapeutics (SRPT) United States $6.883B 0.00
Galapagos (GLPG) Belgium $6.575B 0.00
Halozyme Therapeutics (HALO) United States $6.101B 282.06
Amicus Therapeutics (FOLD) United States $5.988B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.964B 17.44
NeoGenomics (NEO) United States $5.863B 1760.33
Blueprint Medicines (BPMC) United States $5.794B 19.18
Emergent Biosolutions (EBS) United States $5.705B 18.72
Beam Therapeutics (BEAM) United States $5.677B 0.00
Certara (CERT) United States $5.097B 0.00
Eidos Therapeutics (EIDX) United States $4.702B 0.00
China Biologic Products (CBPO) China $4.638B 30.06
Editas Medicine (EDIT) United States $4.569B 0.00
Arena Pharmaceuticals (ARNA) United States $4.555B 0.00
Vir Biotechnology (VIR) United States $4.529B 0.00
Intellia Therapeutics (NTLA) United States $4.491B 0.00
Reata Pharmaceuticals (RETA) United States $4.118B 0.00
Arvinas (ARVN) United States $3.990B 0.00
MorphoSys AG (MOR) Germany $3.751B 135.76
Legend Biotech (LEGN) United States $3.709B 0.00
Insmed (INSM) United States $3.706B 0.00
Alkermes (ALKS) Ireland $3.473B 34.09
Bluebird Bio (BLUE) United States $3.285B 0.00
Global Blood Therapeutics (GBT) United States $3.031B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.940B 0.00
I-Mab (IMAB) China $2.907B 0.00
Intra-Cellular Therapies (ITCI) United States $2.713B 0.00
Zymeworks (ZYME) Canada $2.427B 0.00
Seres Therapeutics (MCRB) United States $2.360B 0.00
Amarin (AMRN) Ireland $2.331B 0.00
Arcus Biosciences (RCUS) United States $2.316B 0.00
Sangamo Therapeutics (SGMO) United States $2.192B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.189B 0.00
Viela Bio (VIE) United States $1.988B 0.00
Revance Therapeutics (RVNC) United States $1.928B 0.00
Sorrento Therapeutics (SRNE) United States $1.912B 0.00
Genetron Holdings (GTH) China $1.878B 0.00
Myriad Genetics (MYGN) United States $1.867B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.849B 15.30
Scholar Rock Holding (SRRK) United States $1.799B 0.00
Ligand Pharmaceuticals (LGND) United States $1.788B 46.33
REGENXBIO (RGNX) United States $1.774B 0.00
NGM Biopharmaceuticals (NGM) United States $1.774B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.768B 0.00
PHARMA MAR SA (PHMMF) Spain $1.746B 0.00
UniQure (QURE) Netherlands $1.692B 0.00
Vericel (VCEL) United States $1.677B 0.00
NantKwest (NK) United States $1.605B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.600B 0.00
Inovio Pharmaceuticals (INO) United States $1.563B 0.00
Precigen (PGEN) United States $1.562B 0.00
Zealand Pharma (ZEAL) Denmark $1.493B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.477B 0.00
Castle Biosciences (CSTL) United States $1.474B 0.00
Heska (HSKA) United States $1.441B 0.00
Travere Therapeutics (TVTX) United States $1.439B 0.00
Codexis (CDXS) United States $1.381B 0.00
Cytokineticsorporated (CYTK) United States $1.364B 0.00
Mersana Therapeutics (MRSN) United States $1.310B 0.00
Zealand Pharma (ZLDPF) Denmark $1.287B 0.00
Antibe Therapeutics (ATBPF) Canada $1.256B 0.00
Cellectis S.A (CLLS) France $1.243B 0.00
Coherus BioSciences (CHRS) United States $1.242B 8.21
Alector (ALEC) United States $1.212B 0.00
Mesoblast (MESO) Australia $1.192B 0.00
Epizyme (EPZM) United States $1.171B 0.00
Frequency Therapeutics (FREQ) United States $1.165B 0.00
Northwest Biotherapeutics (NWBO) United States $1.152B 0.00
Adverum Biotechnologies (ADVM) United States $1.109B 0.00
MiMedx (MDXG) United States $1.011B 0.00
Athenex (ATNX) United States $0.997B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.987B 0.00
Pliant Therapeutics (PLRX) United States $0.983B 0.00
Sutro Biopharma (STRO) United States $0.979B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.957B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.943B 0.00
Morphic Holding (MORF) United States $0.939B 0.00
Pharming Group (PHGUF) Netherlands $0.920B 24.50
Compugen (CGEN) Israel $0.918B 0.00
Cara Therapeutics (CARA) United States $0.871B 0.00
Bionano Genomics (BNGO) United States $0.862B 0.00
Protagonist Therapeutics (PTGX) United States $0.816B 0.00
Avid Bioservices (CDMO) United States $0.771B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.766B 38.89
Adaptimmune Therapeutics (ADAP) United Kingdom $0.757B 0.00
VBI Vaccines (VBIV) United States $0.746B 0.00
Kadmon Holdings (KDMN) United States $0.736B 0.00
MannKind (MNKD) United States $0.735B 0.00
Albireo Pharma (ALBO) United States $0.707B 0.00
Celldex Therapeutics (CLDX) United States $0.695B 0.00
Syros Pharmaceuticals (SYRS) United States $0.688B 0.00
AnaptysBio (ANAB) United States $0.653B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.651B 0.00
Merus (MRUS) Netherlands $0.643B 0.00
Sinovac Biotech (SVA) China $0.640B 35.94
Affimed (AFMD) Germany $0.636B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.628B 0.00
Curis (CRIS) United States $0.620B 0.00
Cardiff Oncology (CRDF) United States $0.619B 0.00
MeiraGTx Holdings (MGTX) United States $0.618B 0.00
Agenus (AGEN) United States $0.607B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.606B 0.00
Five Prime Therapeutics (FPRX) United States $0.569B 0.00
Anika Therapeutics (ANIK) United States $0.568B 76.89
Dynavax Technologies (DVAX) United States $0.561B 0.00
Prothena (PRTA) Ireland $0.543B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.541B 0.00
Pandion Therapeutics (PAND) United States $0.540B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.535B 0.00
Cel-Sci (CVM) United States $0.525B 0.00
Precision BioSciences (DTIL) United States $0.514B 0.00
Geron (GERN) United States $0.503B 0.00
Clovis Oncology (CLVS) United States $0.496B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.475B 0.00
FORTE BIOSCIENC (FBRX) United States $0.469B 0.00
Starpharma Holdings (SPHRY) Australia $0.467B 0.00
AquaBounty Technologies (AQB) United States $0.465B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.460B 0.00
Amryt Pharma (AMYT) United Kingdom $0.460B 0.00
BioDelivery Sciences (BDSI) United States $0.452B 21.29
XOMA (XOMA) United States $0.446B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.445B 0.00
Spero Therapeutics (SPRO) United States $0.437B 0.00
WAVE Life Sciences (WVE) Singapore $0.432B 0.00
AMMO (POWW) United States $0.431B 0.00
Puma Biotechnology (PBYI) United States $0.429B 0.00
UROGEN PHARMA (URGN) United States $0.424B 0.00
Kala Pharmaceuticals (KALA) United States $0.421B 0.00
AC Immune SA (ACIU) Switzerland $0.415B 0.00
DBV Technologies S.A (DBVT) France $0.410B 0.00
Verastem (VSTM) United States $0.402B 0.00
ANI Pharmaceuticals (ANIP) United States $0.393B 10.00
Athersys (ATHX) United States $0.384B 0.00
Cue Biopharma (CUE) United States $0.383B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.379B 0.00
Innate Pharma S.A (IPHA) France $0.371B 0.00
Selecta Biosciences (SELB) United States $0.362B 0.00
CytomX Therapeutics (CTMX) United States $0.355B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.351B 0.00
Trevena (TRVN) United States $0.349B 0.00
Cellular Biomedicine (CBMG) United States $0.347B 0.00
Arbutus Biopharma (ABUS) United States $0.343B 0.00
NextCure (NXTC) United States $0.333B 0.00
Fortress Biotech (FBIO) United States $0.324B 0.00
Voyager Therapeutics (VYGR) United States $0.321B 8.24
Kamada (KMDA) Israel $0.314B 14.71
Lineage Cell Therapeutics (LCTX) United States $0.306B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.303B 0.00
ChromaDex (CDXC) United States $0.284B 0.00
PDL BioPharma (PDLI) United States $0.282B 0.00
CorMedix Inc (CRMD) United States $0.277B 0.00
Bellus Health (BLU) Canada $0.265B 0.00
IBio (IBIO) United States $0.262B 0.00
HOOKIPA Pharma (HOOK) United States $0.236B 0.00
Cogent Biosciences (COGT) United States $0.232B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.231B 0.00
Aptinyx (APTX) United States $0.230B 0.00
Gritstone Oncology (GRTS) United States $0.218B 0.00
Checkpoint Therapeutics (CKPT) United States $0.212B 0.00
Exicure (XCUR) United States $0.210B 0.00
Pluristem Therapeutics (PSTI) Israel $0.208B 0.00
GENFIT S.A (GNFT) France $0.207B 0.00
Cerecor (CERC) United States $0.205B 0.00
Biofrontera AG (BFRA) Germany $0.205B 0.00
TELA Bio (TELA) United States $0.202B 0.00
Theratechnologies (THTX) Canada $0.199B 0.00
Strongbridge Biopharma (SBBP) United States $0.198B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.198B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
VolitionRX (VNRX) United States $0.196B 0.00
ADMA Biologics Inc (ADMA) United States $0.195B 0.00
Kindred Biosciences (KIN) United States $0.191B 0.00
Clearside Biomedical (CLSD) United States $0.191B 0.00
Nicox SA (NICXF) France $0.182B 0.00
Palatin Technologies (PTN) United States $0.180B 0.00
DiaMedica Therapeutics (DMAC) United States $0.180B 0.00
Lumos Pharma (LUMO) United States $0.179B 0.00
Abeona Therapeutics (ABEO) United States $0.176B 0.00
VTv Therapeutics (VTVT) United States $0.167B 0.00
Oncobiologics (OTLK) United States $0.153B 0.00
Idera Pharmaceuticals (IDRA) United States $0.151B 0.00
Aptevo Therapeutics (APVO) United States $0.149B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.149B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.148B 0.00
Dyadic (DYAI) United States $0.145B 0.00
Evogene (EVGN) Israel $0.143B 0.00
TRACON Pharmaceuticals (TCON) United States $0.142B 0.00
Prima BioMed (IMMP) Australia $0.139B 0.00
Catalyst Biosciences (CBIO) United States $0.139B 0.00
Enzo Biochem (ENZ) United States $0.137B 0.00
Protalix BioTherapeutics (PLX) Israel $0.127B 0.00
Liquidia Technologies (LQDA) United States $0.127B 0.00
Orgenesis (ORGS) United States $0.124B 257.00
Ecology Coatings (ABVC) United States $0.123B 0.00
Cyclerion Therapeutics (CYCN) United States $0.122B 0.00
Prometic Life Sciences (LMNL) Canada $0.119B 0.00
AIT Therapeutics (XAIR) United States $0.118B 0.00
PHASEBIO PHARMA (PHAS) United States $0.117B 0.00
Applied Genetic Technologies (AGTC) United States $0.116B 0.00
Celyad SA (CYAD) Belgium $0.112B 0.00
Synlogic (SYBX) United States $0.111B 0.00
Cidara Therapeutics (CDTX) United States $0.105B 0.00
Cocrystal Pharma (COCP) United States $0.102B 0.00
Vascular Biogenics (VBLT) Israel $0.102B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
Windtree Therapeutics (WINT) United States $0.099B 0.00
Novogen (KZIA) Australia $0.096B 0.00
ARAVIVE, INC (ARAV) United States $0.090B 0.00
Aytu Bioscience (AYTU) United States $0.090B 0.00
Organovo Holdings (ONVO) United States $0.088B 0.00
MiRagen Therapeutics (MGEN) United States $0.087B 0.00
Stealth BioTherapeutics (MITO) United States $0.081B 38.75
CollPlant Holdings (CLGN) Israel $0.079B 0.00
Seelos Therapeutics (SEEL) United States $0.077B 0.00
CytRx (CYTR) United States $0.075B 0.00
Adocia (ADOCY) France $0.074B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Purple Biotech (PPBT) Israel $0.067B 0.00
AnPac Bio-Medical Science (ANPC) China $0.067B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.063B 0.00
Genetic Technologies (GENE) Australia $0.059B 0.00
Emmaus Life Sciences (EMMA) United States $0.059B 0.00
Happiness Biotech Group (HAPP) China $0.056B 0.00
Yumanity Therapeutics (YMTX) United States $0.056B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.056B 0.00
Appili Therapeutics (APLIF) Canada $0.055B 0.00
Vaccinex (VCNX) United States $0.054B 0.00
Edesa Biotech (EDSA) Canada $0.052B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.051B 0.00
Cleveland BioLabs (CBLI) United States $0.049B 0.00
Acorda Therapeutics (ACOR) United States $0.049B 0.00
Advaxis (ADXS) United States $0.045B 0.00
BioCardia (BCDA) United States $0.045B 0.00
Pulmatrix (PULM) United States $0.044B 0.00
AEterna Zentaris (AEZS) United States $0.043B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.043B 0.00
Chanticleer Holdings (SONN) United States $0.042B 0.00
Soligenix (SNGX) United States $0.042B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Spherix (AIKI) United States $0.039B 0.00
IMMURON (IMRN) Australia $0.038B 0.00
Prana Biotechnology (ATHE) Australia $0.036B 0.00
Celsion (CLSN) United States $0.034B 0.00
Alimera Sciences (ALIM) United States $0.031B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.029B 0.00
Neuralstem (SNCA) United States $0.025B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Cesca Therapeutics (THMO) United States $0.019B 0.00
GeoVax Labs (GOVX) United States $0.018B 0.00
Invo BioScience (INVO) United States $0.015B 0.00
BioPharmX (TMBR) United States $0.014B 0.00
CTD Holdings (CYTH) United States $0.009B 0.00
Enveric Biosciences (ENVB) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.004B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00